tiprankstipranks
OKYO Pharma Limited Sponsored ADR (OKYO)
NASDAQ:OKYO
US Market
OKYO
OKYO Pharma Limited Sponsored ADR
RESEARCH TOOLSreports

OKYO Pharma Limited Sponsored ADR (OKYO) Stock News & Sentiment

117 Followers
OKYO Pharma to Showcase Urcosimod Data and Convene Key Advisory Board at 2026 ASCRS Meeting
Premium
Company Announcements
OKYO Pharma to Showcase Urcosimod Data and Convene Key Advisory Board at 2026 ASCRS Meeting
2d ago
6K
OKYO
OKYO Pharma Chairman Increases Stake Following Positive Neuropathic Corneal Pain Trial
Premium
Company Announcements
OKYO Pharma Chairman Increases Stake Following Positive Neuropathic Corneal Pain Trial
21d ago
6K
OKYO
OKYO Pharma Director Boosts Stake as Lead Eye-Pain Drug Advances Toward Phase 2b/3
Premium
Company Announcements
OKYO Pharma Director Boosts Stake as Lead Eye-Pain Drug Advances Toward Phase 2b/3
21d ago
6K
OKYO
OKYO Pharma Executive Increases Stake Following Positive Urcosimod Trial Progress
Premium
Company Announcements
OKYO Pharma Executive Increases Stake Following Positive Urcosimod Trial Progress
21d ago
6K
OKYO
OKYO Pharma Raises About $22 Million After Underwriter Partially Exercises Share Option
Premium
Company Announcements
OKYO Pharma Raises About $22 Million After Underwriter Partially Exercises Share Option
28d ago
6K
OKYO
OKYO Pharma’s Urcosimod NCP Data Selected for Presentation at ARVO 2026
Premium
Company Announcements
OKYO Pharma’s Urcosimod NCP Data Selected for Presentation at ARVO 2026
2M ago
6K
OKYO
OKYO Pharma Prices $20 Million Underwritten Share Offering to Fund Clinical Development
Premium
Company Announcements
OKYO Pharma Prices $20 Million Underwritten Share Offering to Fund Clinical Development
2M ago
6K
OKYO
More OKYO News >

OKYO News on the Web

OKYO Pharma to hold Scientific Advisory Board meeting at ASCRS 2026
Proactive Investors
Bullish
OKYO Pharma advances clinical strategy with SAB meeting and ASCRS presentation
Proactive Investors
Bullish
OKYO Pharma to Showcase Urcosimod Data and Convene Key Advisory Board at 2026 ASCRS Meeting
TipRanks News
Neutral
OKYO Pharma Chairman Increases Stake Following Positive Neuropathic Corneal Pain Trial
TipRanks News
Neutral
OKYO Pharma Director Boosts Stake as Lead Eye-Pain Drug Advances Toward Phase 2b/3
TipRanks News
Bearish
Okyo Pharma director John Brancaccio acquires 5,000 shares
TipRanks News
Bullish
OKYO Pharma Executive Increases Stake Following Positive Urcosimod Trial Progress
TipRanks News
Neutral
Okyo Pharma CDO, director acquire shares
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
OKYO
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OKYO’s Media Buzz Sentiment?
3 articles about OKYO were published this week. In an average week, 2.5 articles are published.
    What is OKYO’s weekly average amount of articles?
    In an average week, 2.5 articles about OKYO are published.
      What is OKYO’s News Sentiment?
      100% of articles about OKYO were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week